AAP endorses pediatric drug, device safety legislation

Article

The American Academy of Pediatrics has commended the US Senate for passing the Food and Drug Administration Safety and Innovation Act and calls on the US House of Representatives to quickly pass companion legislation.

The American Academy of Pediatrics (AAP) has commended the US Senate for passing the Food and Drug Administration (FDA) Safety and Innovation Act (S. 3187) and calls on the US House of Representatives to quickly pass companion legislation.

The legislation passed by the Senate would reauthorize FDA user-fee programs and extend 3 laws that govern the safety and effectiveness of drugs and medical devices used to treat children.

The new law strengthens the Best Pharmaceuticals for Children Act, which promotes pediatric drug studies, and the Pediatric Research Equity Act, which requires that pharmaceutical companies conduct research on pediatric applications of adult drugs.

Recent Videos
Decreasing antibiotics for acute otitis media and community acquired pneumonia, with Elysha Pifko, MD
Sensory play for children with autism, with Joshua Feder, MD
Stephanie Chao, MD
Feasibility of ambulatory blood pressure monitoring in primary care | Carissa Baker-Smith, MD, MPH
Tina Tan, MD
Camille Walker CPNP-PC, MSN, CPNP Sacheen D. Harris MSN, CPNP-PC
Danielle Van Damme, DNP, CPNP-AC
Karen Y. Capusan, DNP, CPNP-PC
Discussion: AAP's opioid for acute pain clinical practice guideline with Jessica Spruit, DNP
Bobbie Monaco, MSN, CPNP-PC
© 2025 MJH Life Sciences

All rights reserved.